.
.
.
Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R.
.
The SIC protocol: A seven-step strategy to minimize complications potentially related to the insertion of centrally inserted central catheters.
Brescia F, Pittiruti M, Ostroff M, Spencer TR, Dawson RB. Brescia F, et al.
. Nature. 2021 Sep;597(7877):561-565. doi: 10.1038/s41586-021-03887-4. Epub 2021 Sep 8. Nature. 2021. PMID: 34497418
- Gluten intolerance a significant risk factor
- Infectious disease of the uterus
- Absence of an individual specific disease